Iuliia Antonova/iStock via Getty Images By Warren Patterson , Head of Commodities Strategy | Ewa Manthey , Commodities Strategist Energy - Duration of disruptions key for energy markets The oil market pared some of its initial gains yesterday, with Brent settling 7.26% higher on the day after initially trading as much as 13.6% higher. The market continues to digest the risk of escalation in the Mi...
Iuliia Antonova/iStock via Getty Images By Warren Patterson , Head of Commodities Strategy | Ewa Manthey , Commodities Strategist Energy - Duration of disruptions key for energy markets The oil market pared some of its initial gains yesterday, with Brent settling 7.26% higher on the day after initially trading as much as 13.6% higher. The market continues to digest the risk of escalation in the Middle East. While there are concerns about oil flows through the Strait of Hormuz, a greater risk to the market would be Iran targeting additional energy infrastructure in the region. This could lead to more prolonged outages. Oil price movements have been fairly modest, given the amount of supply at risk and uncertainty about how long disruptions could persist. Part of the explanation: the market had already been pricing in a fairly large risk premium in the lead-up to these attacks. Also, the market appears to be pricing in a relatively short-lived disruption to oil flows through the Strait of Hormuz, which the large surplus markets expect this year should be able to absorb. Clearly, supply disruptions leave significant tightness in the prompt market, as reflected in timespreads. The 12-month ICE Brent is surging from less than US$5/bbl to a little over US$9.50/bbl backwardation. The May/Jun spread surged towards a US$1.60/bbl backwardation. Secretary of State Marco Rubio said that the US will announce plans on Tuesday to mitigate higher energy costs. At the same time, though, there have been reports that the US has no immediate plan to release oil from its strategic petroleum reserve. The longer the Middle East disruptions last, the more likely we are to see coordinated emergency releases from several countries. The middle distillate market saw significant strength. The ICE gasoil market settled almost 18% higher yesterday, while the gasoil crack surged above $36/bbl. At risk is 6m b/d of refined product flows through the Strait of Hormuz. Disruptions in crude oil flows a...
Micron Technology (MU) has officially inaugurated its high-tech semiconductor assembly and test facility in Sanand, Gujarat, marking a watershed moment for India’s burgeoning electronics manufacturing sector. The ISO 9001:2015-certified site has transitioned from construction to active commercial production, signaling the arrival of large-scale semiconductor backend operations in the South Asian n...
Micron Technology (MU) has officially inaugurated its high-tech semiconductor assembly and test facility in Sanand, Gujarat, marking a watershed moment for India’s burgeoning electronics manufacturing sector. The ISO 9001:2015-certified site has transitioned from construction to active commercial production, signaling the arrival of large-scale semiconductor backend operations in the South Asian nation. Investment and Infrastructure Scale The project represents a massive collaborative financial commitment, totaling approximately $2.75 billion. This investment is a joint effort between Micron and its various government partners, supported by the Indian central government’s Modified Assembly, Testing, Marking, and Packaging (ATMP) scheme. The physical scale of the Sanand plant is equally impressive. Once the first phase reaches full operational capacity, the facility will boast over 500,000 square feet of cleanroom space. Remarkably, this makes it one of the largest single-floor assembly and test cleanrooms in the world. This infrastructure is designed to process advanced DRAM and NAND wafers—sourced from Micron’s extensive global manufacturing network—and transform them into finished, market-ready memory and storage solutions. Powering the AI Revolution The timing of the opening is strategic. As the global demand for memory and storage products continues to skyrocket, largely catalyzed by the rapid expansion of Artificial Intelligence (AI) and high-performance computing, the Sanand facility will serve as a critical node in Micron’s global supply chain. To mark the ceremonial start of operations, Micron delivered its first shipment of India-made memory modules to Dell Technologies (DELL). These components are destined for laptops manufactured within India, specifically for the domestic market, highlighting a localized “closed-loop” manufacturing success story. Production Roadmap and Economic Impact Micron has set ambitious scaling targets for the new site: 2026: Expec...
Justin Paget/DigitalVision via Getty Images Investment overview I wrote about Amrize AG ( AMRZ ) previously with a buy rating, as the underlying demand drivers remain intact and the developments (cost savings initiatives working and new capacity) make the story much more attractive. I believe the equity story has improved. Commercial demand is showing up more clearly, especially in data centers an...
Justin Paget/DigitalVision via Getty Images Investment overview I wrote about Amrize AG ( AMRZ ) previously with a buy rating, as the underlying demand drivers remain intact and the developments (cost savings initiatives working and new capacity) make the story much more attractive. I believe the equity story has improved. Commercial demand is showing up more clearly, especially in data centers and other project-driven work. At the same time, ASPIRE is already delivering savings, and new capacity is starting to come online. I reiterate a buy rating. 4Q25 earnings AMRZ reported Q4 2025 revenue of ~$2.84 billion, down 0.4% y/y. That may not look exciting on the surface, but the mix tells a different story. Building Materials revenue was $2.16 billion, up 3.9%, while Building Envelope revenue was $678 million, down 11.8%. Clearly, Building Materials did better. Cement volumes were up 3.6%, and aggregates volumes were also up 3%. Pricing-wise, aggregate pricing on a freight-adjusted constant-currency basis went up 3.8%, while cement pricing fell 0.8%. Building Envelope was the weaker segment here. Revenue fell 11.8%, and management said softer residential roofing demand was the main reason. That said, it was not weak across every line item. Commercial re-roofing revenue was up, and management said commercial new construction tied to data centers remained robust. It also pointed to early recovery in warehousing, distribution, and logistics. Margins and profits followed the same pattern. Building Materials adj. EBITDA was $705 million, up 4.9% y/y, and adj. EBITDA margin improved 60 bps to 32.6%. Building Envelope adj. EBITDA was $130 million, down 23.5%, with the decline driven by softer residential roofing demand and an $8 million increase in warranty provisions, partly offset by better commercial roofing margins from repair and refurbishment work. At the consolidated level, adj. EBITDA was $779 million, down 1.5% year over year. Commercial demand now showing up in the ...
Intel Corporation INTC has gained 100.6% over the past year compared with the industry’s growth of 51.6%. It has outperformed compared to the Zacks Computer & Technology sector and the S&P 500. Image Source: Zacks Investment Research The company has outperformed its peer, NVIDIA Corporation NVDA, but underperformed Advanced Micro Devices AMD. AMD has surged 103.8%, while NVIDIA has gained 55.3% du...
Intel Corporation INTC has gained 100.6% over the past year compared with the industry’s growth of 51.6%. It has outperformed compared to the Zacks Computer & Technology sector and the S&P 500. Image Source: Zacks Investment Research The company has outperformed its peer, NVIDIA Corporation NVDA, but underperformed Advanced Micro Devices AMD. AMD has surged 103.8%, while NVIDIA has gained 55.3% during this period. INTC Gains from AI-Related Demand, Product Innovation Intel is benefiting from solid demand in the Data Center and AI group. The company reported the fastest sequential growth in the data center business this quarter. It reported revenues of $4.7 billion, up 15% sequentially, with an operating margin of 26.4%. The growth is primarily driven by Xeon server CPUs, which are Granite Rapids, Emerald Rapids and Sapphire Rapids. Per a report from Grand View Research, the AI infrastructure market was valued at $223.45 billion in 2024 and is expected to witness a compound annual growth rate of 30.4% by 2030. Intel, with its robust portfolio, is expected to gain from this market trend. AI clusters require massive interconnect bandwidth. High networking demand in the AI buildouts is driving growth in the custom Application-Specific Integrated Circuit (ASIC) business. The company is gaining solid traction in the hyperscaler business. Its ASIC business grew more than 50% in 2025, 26% sequentially and reached an annualized revenue run rate greater than $1 billion in the fourth quarter. Diversification beyond the Xeon business is a positive. Its Client Computing Group is also benefiting from healthy traction in the AI pc market. AI PC shipments grew 16% year over year in the fourth quarter. Intel AI chips are now powering more than 200 notebook designs. The AI PC market is expected to grow substantially in the upcoming quarters, backed by rapid digital transformation initiatives across sectors. Intel’s leading-edge Core Ultra Series 3 processors are expected to gain from...
arlutz73/iStock Editorial via Getty Images Shares of Lincoln National ( LNC ) have been a poor performer over the past year, losing about 9% of their value. While the company has made tremendous progress in turning around results, optimism in its own turnaround has been overwhelmed by fears around private credit losses. I last covered Lincoln in November when I upgraded the stock to a “ B uy.” Whi...
arlutz73/iStock Editorial via Getty Images Shares of Lincoln National ( LNC ) have been a poor performer over the past year, losing about 9% of their value. While the company has made tremendous progress in turning around results, optimism in its own turnaround has been overwhelmed by fears around private credit losses. I last covered Lincoln in November when I upgraded the stock to a “ B uy.” While shares initially rallied, private credit fears have reversed this, leaving shares 16% lower, a very disappointing performance. With updated financials and growing credit fears, now is a good time to revisit LNC. I view the pullback as an opportunity. Seeking Alpha Private credit fears have dominated the landscape so far in 2026, so it is worth starting there when looking at Lincoln. First, last year, the company reached a deal to sell a 9.9% stake to Bain Capital, and as part of this agreement , Bain will manage a $20 billion portion of its investment account. This allocation is primarily focused on private credit and alternatives. Lincoln, in part, reached this agreement because its stand-alone private credit origination capacity was comparatively weak, and enhancing yields is essential to compete in the RILA (registered index-linked annuity) market against PE-backed firms. The fact there is now so much fear about potential losses in private asset classes should make the fact that LNC has less exposure a positive attribute. In fact, now may be an ideal time to grow exposure to the segment as lenders are positioned to demand much better terms than just 12 months ago, which should be a positive for its growing commitment to Bain. However, this sell-off on credit loss fears has been fairly indiscriminate, leaving LNC vulnerable to a downdraft. Beyond this, its portfolio is very high-quality, and 97% of its portfolio is investment grade. During the quarter, Lincoln deployed new funds at 5.3%, 65bps above its portfolio yield. I expect new investments to remain accretive to b...
Key Points Despite a recent pullback, Bitcoin is still up nearly 15% for the year. On a relative basis, Bitcoin is outperforming every other top cryptocurrency. Institutional investors are increasingly embracing Bitcoin as "digital gold." 10 stocks we like better than Bitcoin › After a promising start to the year, the crypto market is now in a deep funk. There's no other way to describe its recent...
Key Points Despite a recent pullback, Bitcoin is still up nearly 15% for the year. On a relative basis, Bitcoin is outperforming every other top cryptocurrency. Institutional investors are increasingly embracing Bitcoin as "digital gold." 10 stocks we like better than Bitcoin › After a promising start to the year, the crypto market is now in a deep funk. There's no other way to describe its recent performance. Of the top 50 cryptocurrencies by market cap, only a handful are in the green over the past 30 days. Everywhere else, there is a sea of red. But don't despair. There's one top cryptocurrency that's still worth buying. In fact, it is likely to outperform the broader market over both the short term and the long term. Yes, I'm talking about Bitcoin (CRYPTO: BTC). Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Bitcoin vs. altcoins Let's start by surveying the recent carnage in the crypto market. Over the past 30 days, Bitcoin is down nearly 10%, and some are now concerned that the world's most popular cryptocurrency might dip below the $100,000 mark. But if you zoom out, an entirely different picture emerges. Major altcoins are down anywhere from 15% to 30% across the board. Ethereum, for example, is down 15%. Solana is down 20%, XRP is down 25%, and Cardano is down 30%. And don't even think about investing in meme coins right now. Shiba Inu is down 25%, Dogecoin is down 30%, and Pepe is down 40%. Against that backdrop, Bitcoin's performance over the past 30 days becomes much less disappointing. It's hard to call Bitcoin a "store of value" right now, given its recent decline. But it is definitely holding up better than other top cryptocurrencies. For the year, Bitcoin is still up nearly 15%. The debasement trade One reason why Bitcoin is holding up better than major altcoins is something called the "debasement trade." This trade is currently the newest obsession on Wall Street:...
Thai court issued arrest warrants for a foreign businessman and his wife accused of investment fraud and money laundering, with one victim allegedly conned out of more than US$30 million, police said. Thailand’s Central Investigation Bureau (CIB) accused Ben Smith, also identified in news reports as South African Benjamin Mauerberger, and his wife, Cattaliya Beevor, of “cross-border investment fra...
Thai court issued arrest warrants for a foreign businessman and his wife accused of investment fraud and money laundering, with one victim allegedly conned out of more than US$30 million, police said. Thailand’s Central Investigation Bureau (CIB) accused Ben Smith, also identified in news reports as South African Benjamin Mauerberger, and his wife, Cattaliya Beevor, of “cross-border investment fraud” dating back to 2016, according to a statement from the bureau on Monday. Media reports have previously linked Smith to transnational scam operations in Cambodia , part of a multibillion-dollar illicit industry that has ballooned in the region. Advertisement Thai Prime Minister Anutin Charnvirakul – who told reporters in December that he knew Smith “but was not close” to him – said on Monday that the warrants were in line with the government’s policy of cracking down on scammers and money launderers “regardless of who they are”. Ben Smith, also known as Benjamin Mauerberger, is accused of cross-border investment fraud dating back to 2016. Photo: Handout A criminal court issued the arrest warrants on fraud and money laundering charges on Thursday. Advertisement Smith, 47, and Beevor, 40, were accused of deceiving an unnamed foreign victim into investing in stocks, real estate, a private jet and energy businesses, building credibility until the victim “believed the schemes and transferred more than one billion baht (US$31.8 million)”, the investigation bureau said.
Editor's note: Seeking Alpha is proud to welcome Joseph Minton as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access. Click here to find out more » Nemes Laszlo/iStock via Getty Images Getting diagnosed with an autoimmune disease called Ulcerative...
Editor's note: Seeking Alpha is proud to welcome Joseph Minton as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access. Click here to find out more » Nemes Laszlo/iStock via Getty Images Getting diagnosed with an autoimmune disease called Ulcerative Colitis, a form of IBD, was a harsh reality check for me. I was told the disease was chronic and that I would have to take medicine for the rest of my life. And it’s true, I still see 60 more years of medicine ahead, but maybe now science offers the autoimmune disease patient a possible cure. Yes, a cure for once-thought-incurable diseases. A one-and-done treatment, no more lifelong infusions and prolonged side effects from regular dosing. CAR-T cell therapy proudly boasts the possibility of drug-free remission, and Kyverna Therapeutics ( KYTX ) leads the charge. It almost sounds too good to be true for a group of over 50 million Americans who fight daily with their autoimmune diseases. The State of CAR-T CAR-T treatment is associated with the oncology sector. Think lymphoma, leukemia, and myeloma. When researchers were first studying the possibility of taking a patient’s T-cells outside of their body for programming, the obvious next step was to program the T-cells to destroy B-cells, as B-cells cause certain cancers like B-cell lymphomas and leukemias. The risk was that these T-cells would work so well that they would annihilate all of the B-cells, good ones too, similar to the risks that chemo presents. Fortunately, scientists knew that B-cells can regenerate from bodily stem cells in a matter of weeks, and with that knowledge in hand, the FDA approved the first CAR-T therapies in 2017 for blood cancers. Miracles were worked in patients thought to have no options. Today, the CAR-T market has blossomed to $4.6-8.9B and is projected to reach $15-44B by 2030. Researchers t...
Broadcom Inc. (NASDAQ:AVGO) is one of the stocks in focus this week under Jim Cramer’s game plan. Cramer highlighted the hurdles faced by the stock, as he remarked: After the close, Broadcom reports… $1.5 trillion company makes semis and software, really doesn’t get enough attention given its size. Now, some of the chips are sold to Alphabet, which is a big buyer. That said, Broadcom needs to get ...
Broadcom Inc. (NASDAQ:AVGO) is one of the stocks in focus this week under Jim Cramer’s game plan. Cramer highlighted the hurdles faced by the stock, as he remarked: After the close, Broadcom reports… $1.5 trillion company makes semis and software, really doesn’t get enough attention given its size. Now, some of the chips are sold to Alphabet, which is a big buyer. That said, Broadcom needs to get new clients. Right now, it’s caught in the software decline stemming from AI fears. I think the decline’s wrong. You don’t get to $1.5 trillion for doing nothing, right? But you know what? This is one of those that’s just too hard to own right now, and I know that, and I sensed that today when we had our monthly meeting. A stock market graph. Photo by energepic.com Broadcom Inc. (NASDAQ:AVGO) supplies semiconductor devices and infrastructure software, including networking, connectivity, and storage solutions. The company’s products are used for applications in data centers, telecommunications, broadband, smartphones, industrial systems, and AI networking. During the February 3 episode, a caller asked if it was a good time to invest in the company’s stock, and Cramer replied: Okay, I’m [of] two minds on Broadcom. It’s not a good time to get into it, but it’s a great company. So what are we going to do? We’re going to let it come down. It did bounce today. We’re going to hope that Hock Tan does a buyback. He’s got the earnings. I’m going to throw in, let me throw in NVIDIA… This company is a winner in this environment, not a loser. And I will be right. Just going to take a little while. While we acknowledge the potential of AVGO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Y...